Drug Trial Radar · NCT02853552
Misoprostol as First Aid Measure to Address Excessive Postpartum Bleeding
Last checked: Nov 20, 2026Latest source record: Aug 3, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
4,330
Planned (sponsor's estimate)
Start
Oct 2016
Primary completion
Oct 2017
Study completion Oct 2017
Sponsor
- Lead sponsor
- Gynuity Health ProjectsAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Committee for Maternal & Neonatal Health
- First posted
- Aug 3, 2016
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Health services research
- Who can join
- Female only
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The overall study purpose is to evaluate the safety, feasibility and acceptability of advance distribution of misoprostol to be used as 'first aid treatment' administered by the woman herself or her family to help treat excessive bleeding in home births.
Conditions
- Postpartum Hemorrhage
Interventions
MisoprostolDrug
800mcg misoprostol taken sublingually
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of cases identified as having excessive bleedingTime frame: Within 1 week after delivery
- Proportion of women who administer misoprostol as first aidTime frame: Within 1 week after delivery
- Proportion of women who correctly administer misoprostol as first aidTime frame: Within 1 week after delivery
- Acceptability of side effects of misoprostolTime frame: Within 1 week after delivery
- Number of women who are transferred for excessive bleedingTime frame: Within 1 week after delivery
- Proportion of women who experience a serious adverse event due to excessive bleedingTime frame: Within 1 week after delivery
- Proportion of women who receive an additional intervention (e.g. use of additional uterotonic or suturing) for excessive bleedingTime frame: Within 1 week after delivery
- Level of acceptability and satisfaction with using misoprostol as first-aid option to treat excessive bleedingTime frame: Within 1 week after delivery
- Correct comprehension of information related to misoprostol and its use for first aidTime frame: Within 1 week after delivery
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.